Potential protective effect of ovocystatin on aging-related cognitive impairment in rats

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue

Abstract

Introduction: Increased occurrence of cognitive deficits in mild cognitive impairment is related with the phenomenon of aging within the population. Cystatin C has been associated with cysteine protease inhibiting properties as well as an induction of autophagy and proliferation that can potentially be used as an adjuvant in the treatment of cognitive decline. The aim of the study was to evaluate the effect of ovocystatin, which is structurally and biologically similar to cystatin C, on cognitive functions in experimental young and aging rat models. Material/Methods: The young (four-month-old) and aging (ten-month-old) Wistar Crl: Wi (Han) rats received ovocystatin (i.p.) for 12 days at a dose of 200 and 20 μg/rat, respectively. Cognitive functions were determined using the Morris water maze. Results: Ovocystatin treatment at a dose of 200 μg/rat improved the performance of old rats in the Morris water maze test via increasing the spent time and the distance traveled in the target zone but the differences were not statistically significant (p>0.05). The results of the study highlight the important role cystatins play in neurodegenerative processes as well as the influence they have on cognitive functions. Furthermore, the obtained findings suggest ovocystatin may be used in the treatment of mild cognitive impairment or cognitive decline in dementia, but further morphological, biochemical and immunohistochemical studies are needed.

Authors and Affiliations

Bartłomiej Stańczykiewicz, Maria Rutkowska, Marta Lemieszewska, Jakub Gburek, Krzysztof Gołąb, Katarzyna Juszczyńska, Tadeusz Trziszka, Joanna Rymaszewska

Keywords

Related Articles

The influence of IGF-1 on fetal growth during pregnancy complicated by gestational diabetes mellitus

Insulin-like growth factor-1 (IGF-1) is an important part of IGF system. The structure and function of IGF-1 are similar to that of insulin. Thus, IGF-1 may participate both in the gestational diabetes mellitus (GDM) pat...

Współczesne poglądy na etiopatogenezę układowego tocznia rumieniowatego

Praca jest przeglądem informacji literaturowych dotyczących etiopatogenezy układowego tocznia rumieniowatego. Postępy nauki w zakresie poznania mechanizmów obserwowanych zaburzeń oraz wdrażanie odpowiedniego postępowania...

The diagnosis of anthracycline-induced cardiac damage and heart failure

Routine examinations during chemotherapy containing anthracyclines evaluate heart function before treatment and monitor cardiotoxic effects during and after therapy. A number of methods are useful in cardiac assessment,...

Kynurenic acid – a new tool in the treatment of hiperhomocysteinemia and its consequences?

Atherosclerosis together with its cardiovascular consequences is the most common and significant cause of death, particularly in highly developed countries. The process of atherogenesis begins as soon as in childhood an...

Download PDF file
  • EP ID EP248520
  • DOI 10.5604/01.3001.0010.7670
  • Views 120
  • Downloads 0

How To Cite

Bartłomiej Stańczykiewicz, Maria Rutkowska, Marta Lemieszewska, Jakub Gburek, Krzysztof Gołąb, Katarzyna Juszczyńska, Tadeusz Trziszka, Joanna Rymaszewska (2017). Potential protective effect of ovocystatin on aging-related cognitive impairment in rats. Advances in Hygiene and Experimental Medicine, 71(), 1202-1208. https://europub.co.uk/articles/-A-248520